PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.

PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.

<h4>Background & aims</h4>Aim of this study was to evaluate whether the PNPLA3 I148M polymorphism, previously associated with hepatocellular carcinoma (HCC) risk, influences the clinical presentation of HCC and survival.<h4>Methods</h4>we considered 460 consecutive HCC pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Luca Valenti, Benedetta Maria Motta, Giorgio Soardo, Massimo Iavarone, Benedetta Donati, Angelo Sangiovanni, Alessia Carnelutti, Paola Dongiovanni, Raffaela Rametta, Cristina Bertelli, Floriana Facchetti, Massimo Colombo, Silvia Fargion, Anna Ludovica Fracanzani
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/dcbc63d1da6c40f7a2e76c9c1c7a8ecb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/dcbc63d1da6c40f7a2e76c9c1c7a8ecb

Ejemplares similares